EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Translational Challenges and Prospective Solutions in the Implementation of Biomimetic Delivery Systems

Zhe Wang iD, Xinpei Wang, Wanting Xu, Yongxiao Li, Ruizhi Lai, Xiaohui Qiu, Xu Chen, Zhidong Chen, Bobin Mi, Meiying Wu iD, Junqing Wang iD

Pharmaceutics · 14.11.2023 · 15 (11) · 2623

DOI: 10.3390/pharmaceutics15112623 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 14.11.2023. Verfasst von Zhe Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen 518033, China. Die Arbeit wurde bisher 102-mal zitiert (Crossref) und nennt 342 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shenzhen Science and Technology Program, Futian Healthcare Research Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Biomimetic delivery systems (BDSs), inspired by the intricate designs of biological systems, have emerged as a groundbreaking paradigm in nanomedicine, offering unparalleled advantages in therapeutic delivery. These systems, encompassing platforms such as liposomes, protein-based nanoparticles, extracellular vesicles, and polysaccharides, are lauded for their targeted delivery, minimized side effects, and enhanced therapeutic outcomes. However, the translation of BDSs from research settings to clinical applications is fraught with challenges, including reproducibility concerns, physiological stability, and rigorous efficacy and safety evaluations. Furthermore, the innovative nature of BDSs demands the reevaluation and evolution of existing regulatory and ethical frameworks. This review provides an overview of BDSs and delves into the multifaceted translational challenges and present emerging solutions, underscored by real-world case studies. Emphasizing the potential of BDSs to redefine healthcare, we advocate for sustained interdisciplinary collaboration and research. As our understanding of biological systems deepens, the future of BDSs in clinical translation appears promising, with a focus on personalized medicine and refined patient-specific delivery systems.

Schlagwörter

Stichwörter der Autor:innen

albuminbioinspiredbiomimeticextracellular vesiclesferritinliposomesnanodiscspolysaccharidesvirus-like particles

Autor:innen und Institutionen

  • Department of Pathology, The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen 518033, China.
  • School of Pharmaceutical Sciences, Shenzhen Campus of Sun Yat-sen University, Shenzhen 518107, China.
  • Department of Orthopaedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
  • Hubei Province Key Laboratory of Oral and Maxillofacial Development and Regeneration, Wuhan 430022, China.

ORCID-Profile: Zhe Wang, Meiying Wu, Junqing Wang

Förderung

  • National Natural Science Foundation of China
  • Shenzhen Science and Technology Program
  • Futian Healthcare Research Project
  • Program of 'Transverse' Research Project at Sun Yat-sen University
  • Program of ‘Transverse’ Research Project at Sun Yat-sen University

Zitieren

APA

Wang, Z., Wang, X., Xu, W., Li, Y., Lai, R., Qiu, X., Chen, X., Chen, Z., Mi, B., Wu, M., & Wang, J. (2023). Translational Challenges and Prospective Solutions in the Implementation of Biomimetic Delivery Systems. Pharmaceutics, 15(11), 2623. https://doi.org/10.3390/pharmaceutics15112623

Vancouver

Wang Z, Wang X, Xu W, Li Y, Lai R, Qiu X, et al. Translational Challenges and Prospective Solutions in the Implementation of Biomimetic Delivery Systems. Pharmaceutics. 2023;15(11):2623. doi:10.3390/pharmaceutics15112623

BibTeX
@article{Wang2023,
  author = {Wang, Zhe and Wang, Xinpei and Xu, Wanting and Li, Yongxiao and Lai, Ruizhi and Qiu, Xiaohui and Chen, Xu and Chen, Zhidong and Mi, Bobin and Wu, Meiying and Wang, Junqing},
  title = {Translational Challenges and Prospective Solutions in the Implementation of Biomimetic Delivery Systems},
  journal = {Pharmaceutics},
  year = {2023},
  volume = {15},
  number = {11},
  pages = {2623},
  doi = {10.3390/pharmaceutics15112623}
}
Kostenlos starten →